AccSys Delivered First PL-11 linac to FFAG/DDS Research Organization
 

PLEASANTON, Calif., November 11, 2007 --

AccSys Technology, Inc. of Pleasanton, California, today announced that the company’s first LANSAR® Model PL-11(11.0 MeV) proton linear accelerator (linac) has been shipped to and passed the Final Acceptance Test at KURRI (Kyoto University Research Reactor Institute) for a project operated by the FFAG-DDS Research Organization. This project aims to develop a new system and technology for neutron capture therapy funded by NEDO (New Energy and Industrial Technology Development Organization; http://www.nedo.go.jp/english/index.html) in Japan. FFAG-DDS Research Organization is duly organized and existing under the laws of Japan with its place of business at Mita station building AMITA 801, 5-31-7, Shiba, Minato-ku, Tokyo-to, 108-0014 Japan.

In this project, this PL-11 is used as the proton injector of 11.0 MeV to the FFAG (Fixed Field Alternating Gradient) accelerator which is for the neutron source of BNCT (Boron Neutron Capture Therapy). The Project is for R&D on a next-generation DDS-type Malignant Tumor Therapy System. The Project will span three years from FY2005 to FY2007 and represents one of the Biotechnology and Medical Technology Development Projects promoted by NEDO.
 

The Model PL-11 proton linac is a compact linear accelerator consisting of one RFQ (Radio Frequency Quadrupole Linac) and two DTL (Drift Tube Linac) subsystems. This linac represents the upgraded version of the Model PL-7 (7.0 MeV) consisting of one RFQ and one DTL which has been widely used in various commercial, medical and R&D fields. LANSAR® systems from AccSys Technology, Inc. can be powerful neutron sources based on the compact ion linear accelerators (linacs) design. AccSys Technology, Inc.’s unique ion accelerators use proven linac technology to provide systems designed for reliable long-term operation for application in many fields. LANSAR® family has both the proton accelerator (Model PL-4, PL-7 and PL-11) and the deuteron accelerator (Model DL-1, DL-2 and DL-4).
 

AccSys Technology, headquartered in California, USA, is the world’s leading commercial producer of rf ion linacs for medical, industrial and research applications. Founded in 1985 as a design and manufacturing company, AccSys specializes in the development, production, installation and servicing of compact ion linacs using its patented linac technology. AccSys is dedicated to providing the highest quality and most reliable commercial ion linac systems to meet the needs of its customers. For more information on AccSys Technology, Inc., please visit the AccSys web site at http://www.accsys.com. AccSys has been an affiliate of Hitachi, Ltd. since 2002.
 

Hitachi, Ltd., (NYSE: HIT / TSE: 6501), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 384,000 employees worldwide. Fiscal 2006 (ended March 31, 2007) consolidated sales totaled 10,247 billion yen ($89.1 billion). The company offers a wide range of systems, products and services in market sectors including information systems, electronic devices, power and industrial systems, consumer products, materials and financial services. For more information on Hitachi, please visit the company’s website at www.hitachi.com.